chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 3-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
Chills; Fever; Body aches and and pain all over; Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 01:15 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The medical history included diabetes and heart condition. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient received  medications( reported as too many to list) within two weeks of vaccination. The patient previously took prochlorperazine (COMPAZINE) on an unknown date and experienced allergy. On 20Apr2021 at 01:00, the patient experienced chills, fever, pain at injection site, body aches and pain all over. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, pain at injection site, body aches and pain all over  were recovered un an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
In April I fell in the dollar store and I thought I cleared the shelf and fell. After that I had the balancing issues, after that I had eye pain. I did a CT SCAN and it was normal. I went to a eye doctor  he thought the trulicity is what was making my eyes hurt. I called my PCP and told me to not to take it anymore. So, basically I was told it takes 3 weeks for it to get out of my system and it's been over a month and I'm still having the issues.
SENSITIVE SKIN; BODY ACHE; COLD; FELT THAT SHE WAS DYING FROM  WEDNESDAY-THURSDAY; FREEZE; LEG,ARM,BODY HURT; CHILLS; HIGH FEVER AND BURNING FROM INSIDE OUT; HAIR OF HER SKIN STAND; COULD NOT MAKE IT TO JOB; PRICKLY SKIN AND TOOTHPICKS POKING THE SKIN; COULD NOT SLEEP; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown Expiry: Unknown) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination on right deltoid. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced prickly skin. On MAR-2021, the subject experienced could not sleep. On MAR-2021, the subject experienced hair of her skin stand. On MAR-2021, the subject experienced toothpicks poking the skin and toothpicks poking the skin. On MAR-2021, the subject experienced could not make it to job. On 24-MAR-2021, the subject experienced body ache. On 24-MAR-2021,  at 4:30--5:15 PM the subject experienced leg, arm, body hurt. On 24-MAR-2021, the subject experienced cold. On 24-MAR-2021, the subject experienced felt that she was dying from Wednesday-Thursday. On 24-MAR-2021, the subject experienced freeze. On 24-MAR-2021, the subject experienced chills. On 24-MAR-2021, the subject experienced high fever and burning from inside out. Laboratory data included: Body temperature at around At 4:30--5:15 PM (NR: not provided) 101 F. On 25-MAR-2021, the subject experienced sensitive skin. Laboratory data included: Body temperature at night about 1 am (NR: not provided) 103.2 F, 101.9 (units unspecified). On 26-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100.8- 99.5 F Laboratory data included: Body temperature (NR: not provided) 100.8- 99.5 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from high fever and burning from inside out, sensitive skin, chills, and body ache, and the outcome of prickly skin and toothpicks poking the skin, could not sleep, leg,arm,body hurt, hair of her skin stand, toothpicks poking the skin, cold, felt that she was dying from Wednesday-Thursday, freeze and could not make it to job was not reported. This report was non-serious.
A day after the vaccine subject started experiencing blisters all over head and eyes and then spread to arms and legs. Subject went to urgent care on March 21 and was prescribed a medication for itching. On March 22nd subject had no relief so he went to ER because he wasn't getting any relief. Doctor stated he wanted to keep the subject for observation but subject did not want to stay. Subject states the progression stopped about day 7 but still has scabs and wounds that are healing.
Patient's mom states that the patient has been nauseous and vomited daily for 3 weeks since receiving  the covid-19 vaccine
A report has been received from a Health Professional concerning a 14 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. Concomitant medications included Garcinia Cambogia for supplement. FLUMIST QUADRIVALENT started on an 13-NOV-2014. The patient received FLUMIST QUADRIVALENT yesterday and approximately 30 min's after administration patient experienced fatigue, mental status changes, memory loss, and nausea which started on 13-NOV-2014. At the time of reporting, the event of fatigue, mental status changes-memory loss and nausea was improving. The report was considered to be non-serious.
Information has been received from a physician concerning a 15 year old female who in April 2007, was vaccinated intramuscularly with a 0.5 mL dose of Gardasil. There was no concomitant medication. Approximately 6 to 8 hours after vaccination, the patient experienced shortness of breath. Her symptoms lasted "all night long" and resolved by the next morning. Unspecified medical attention was sought. Subsequently, the patient recovered from shortness of breath. Additional information has been requested.
Lymph node on my collar bone on the left side was very swollen and now the area where I got the shot is very red and hot and swollen and my arm and several lymph nodes on the left side are swollen and painful.  feeling very exhausted, nauseated, fever.
Shortness of breath reported as ADR from COVID vaccine. No other information available in regards to when the vaccine was given, time of onset, or other course of events.
Pt recv vax on 12/15/97; on the same day pt exp itching of injection site, redness &swelling of injection site, swelling around the arm.  Pt imp w/o tx.
Chest pain as a result of Pericarditis. 600 MG of Ibuprofen/3x a day. Mitigare 0.6 MG/2x a day. Both meds were prescribed on May 10th, 2021. I've been taking it since and it certainly has been effective. Unfortunately, when attempting to ween off, the symptoms immediately return.
PATIENT REPORTS EXTREME PAIN, REDNESS, AND SWELLING AT INJETION SITE EVEN 3 DAYS LATER
administration of an expired Hiberix dose to a patient.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a female patient who received Hib (Hiberix) (expiry date 27-JUL-2023) for prophylaxis.   On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced expired vaccine used (Verbatim: administration of an expired Hiberix dose to a patient.). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 15-AUG-2023 The healthcare professional called to ask for information regarding the administration of an expired Hiberix dose to a patient.  The healthcare professional asked if there was a grace period to administer a repeat dose. The reporter did not provide patient initials, patient age nor lot number of the Hiberix vaccine. The reporter consented to follow up. The patient received Hiberix beyond the expiration date, which led to expired vaccine used.
Received the vaccine had no reaction, no temp, no headache.  She felt a little funny, and possibly a week later she started getting reaction in her body, burning sensation in her chest, possibly thought related to acid reflux.  She then had sensation down her leg nerve pains.  Sometimes she also gets some hot flashes but they go away.  She woke up early in the morning yesterday and had a pressure like sensation in her head, she still has that today.  She still has burning sensation in her chest, and her legs and ankles are hurting still.   She has taken some Tylenol for the aches and pains.   Also has itchiness of her arm from the vaccine, as well as soreness.
Swelling and itching at both eyes.  Right eye almost swollen shut.  2 inch purple bruise at injection site.
Heart palpitations began about 5 hours after shot . This  also happened after my first shot on 2/27/2021. After my first vaccine I also had heart palpitations after about 5 hours. I went  to the ER. My blood pressure was also slightly elevated
After the second administration of the Pfizer COVID-19 vaccine I experienced chest pain. My first observation was two days after the injection. I?d never had chest pain before so I was concerned but tried to dismiss it as hopefully nothing serious. I?m a young, fit male so I didn?t think it was anything serious. Over the course of the next one to two weeks I continued to have chest pain that would come and go. Thursday, May 27 I experienced very severe chest pain and difficulty breathing. The pain was worse than it had ever been and taking anything more than a shallow breath caused intense pain. I could no longer ignore it so I went to the Hospital. They performed an EKG and chest X-ray. Both results came back normal. They said my heart was fine based on the EKG and my lungs looked fine based on the X-ray. The doctor and PA couldn?t diagnose me. They said it could have been muscle strain of GERD. Neither of these seem likely as I have never experienced anything like this. I exercise often and have never strained my chest to this extent and I have never experienced heartburn. The symptoms subsided later that week and didn?t return even though I did not take any medication or make changes to my lifestyle. Now I have a bill from the hospital that?s over $1000 that is difficult for me to pay.
Cold chills began Sat. after vaccination & patient noticed redness develop on Sunday. Itching was also observed by pt.
Possible UTI; Sore Arm; Aching; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), PAIN (Aching), FATIGUE (Tiredness) and URINARY TRACT INFECTION (Possible UTI) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included PREDNISONE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm), PAIN (Aching) and FATIGUE (Tiredness). On 16-Apr-2021, the patient experienced URINARY TRACT INFECTION (Possible UTI). At the time of the report, PAIN IN EXTREMITY (Sore Arm), PAIN (Aching) and FATIGUE (Tiredness) had resolved and URINARY TRACT INFECTION (Possible UTI) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Provider discharge summary "Patient is a 66 YO female with a PMHx of T2 DM, HTN, permanent Afib on Eliquis, bipolar disorder, CKD stage IIIa, HLD, vascular graft infection on suppressive doxycycline who presented after a ground level fall associated with some dizziness.   Brief Summary of Hospital Stay: Pt was noted to have some hypotension, which improved with holding of her BP meds. Orthostatics and cortisol levels not concerning. BP meds held currently. She did develop AFib with RVR which is improving, BB to continue.    Her MRI lumbar spine showed severe Right foraminal stenosis. This was discussed with NS, and outpatient referral is indicated.    She was found to have an incidental COVID infection and is asymptomatic. "
PT complaining of redness, warmth and inflammation at site of vaccination (he says it's so swollen his skin stretch to the point its shiny). Painful at touch, unable to use arm or sleep on that side. States that reaction occurred the night after vaccination, reported 09/19/15 and has not shown much improvement. PT encouraged to seek urgent care/ER.
RabaVert was administered after temperature excursion; Case reference number US-BN-2021-000244 is a spontaneous case report initially received from a health care professional on 17-Mar-2021, and concerns an 8-year-old female patient.  The patient's medical history was not provided.  The patient's concomitant medication details were not provided.  On 03-Nov-2020, RabAvert vial was affected to temperature excursion (Product storage error).   On 12-Nov-2020, the patient received dose of RabaVert ,that was affected due to temperature excursion (Inactivated Rabies Virus Vaccine, Batch no. AD01A13C) at unknown dosage regimen for post-exposure prophylaxis.  At the time of this report it was not known whether the patient developed any adverse event.  This case is linked with cases US-BN-2020-019887 and US-BN-2021-000243 (same reporter).  Further information was not provided.; Reporter's Comments: Product storage error is listed by convention. Reportedly, the patient received RabAvert that was affected to temperature excursion which is considered to be product storage error. No adverse events were reported. Product storage error is not related to the suspect product but to human action.; Sender's Comments: Product storage error is listed by convention. Reportedly, the patient received RabAvert that was affected to temperature excursion which is considered to be product storage error. No adverse events were reported. Product storage error is not related to the suspect product but to human action.
Approximately 48 or 49 hours after getting the first vaccination shot is when all the adverse conditions began to occur.    I was taking extra strength Tylenol every 3 1/2 hours which would barely minimize any of the problems !!!!     I usually have a body temp of 96.7, but started with a continuous 99.6 to 99.9 fever (six days) and had horrible chills for 4 days.   In addition, I suffered from severe headaches, nose bleeds, nausea, stomach discomfort, total lack of appetite,  EXTREME joint pain from head to toes, EXTREME sensitivity and pain on all skin surfaces (couldn't stand the weight of covers on me and could feel the texture of clothings' materials),  never before sciatica pain down right leg, totally flared up the pain in feet (from previous reaction to Levaquin) to a point of not being able to walk on feet, pain in and around both arm pits,    My blood pressure went totally out of control and kept going up to 190s.     All these "over the top" adverse conditions continued for 6 days --- then on day 7 and 8 they began to let up and I experienced what I would call more like regular "flu like symptoms"  It was as if any flaw or tolerable pre-existing discomforts I have had anywhere in my body were extremely exaggerated .
I felt very tired; Felt sore and achy like I had Flu; Felt sore and achy like I had Flu; Broke out with the rash; rash in my chest and my tummy following day was worst; it came up to my neck, travelling to my arms and my back; I didn't feel good; felling so bad; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date (Lot Number: EN6208) as SINGLE DOSE for covid-19 immunisation; benzylpenicillin sodium (PENICILLINE), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication  .  The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient had gotten the first Pfizer injection last week on Wednesday and might of like an hour later patient felt very tired that was okay. Then next day, the patient just felt sore and achy just like had the Flu and then by the evening patient broke out with the rash. The rash was little bit in chest, it was a little bit in tummy and then the following day was worst. It was travelling, it came up to neck, all arms and my back. It was just a rash but didn't feel good, looking at that of course not feeling good, didn't know how. The patient finally decided because it happened, I pick up some Benadryl and took that for 2 days and half and finally they are going away.  The action taken in response to the events for benzylpenicillin sodium was unknown.  The outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received her first Shingrix vaccination in early October 2020 and she experienced arm pain. The pain continued for weeks, but was resolved. The reporter did not consent to follow up.
A report has been received from a Health Professional concerning a 61 year old, Male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on an unknown date. The public health nurse reported that on 19-Nov-2013, the gave FLUMIST QUADRIVALENT to patient over 49. The outcome of the event of gave FLUMIST QUADRIVALENT to patient over 49 is unknown. The report was considered to be non-serious by reporter.
She developed an itchy rash. She put rubbing alcohol on it. I recommended using either a topical or oral antihistamine. The rash has not resolved. Advised her if it does not clear in another few days to consult a physician
Mild headache; injection site soreness; This is a spontaneous report from a contactable consumer.   A 48-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot # EH9899) at single dose at left arm on 17Dec2020 for an immunization, at Doctor's office/urgent care.  The patient medical history and concomitant medications were not reported. No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received other vaccines within 4 weeks prior to the COVID vaccine.  The patient experienced mild headache and injection site soreness on 17Dec2020. The patient received no treatment. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovered in Dec2020. The events were assessed as non-serious.
does not have taste; does not have smell; Contracted covid; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (does not have taste), ANOSMIA (does not have smell) and COVID-19 (Contracted covid) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced AGEUSIA (does not have taste), ANOSMIA (does not have smell) and COVID-19 (Contracted covid). At the time of the report, AGEUSIA (does not have taste), ANOSMIA (does not have smell) and COVID-19 (Contracted covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Coronavirus test: Positive. On an unknown date, Coronavirus test: (Negative) Retested on unknown date an tested negative..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was reported No treatment information was provided   This case was linked to MOD21-076101,MOD-2021-078210 (E2B Linked Report).; Sender's Comments:  MOD21-076101:crosslink